News search

• ·         The Pro CNIC Foundation prolongs its commitment until 2028, with the excellent cardiovascular research carried out at the CNIC under the management of Dr. Valentín Fuster
• ·         The innovative public-private financing formula has allowed the CNIC to reach a very high level of excellence, making it worthy of the Severo Ochoa accreditation and other international recognitions 
  
• The Pro CNIC joins together 12 of the most important companies in Spain: Acciona, Santander Bank, BBVA, Endesa, Mapfre Foundation, Mutua Madrileña Foundation, Ramón Areces Foundation, Repsol Foundation, Inditex, "la Caixa", Prisa and Telefónica.

Poor quality sleep increases the risk of atherosclerosis according to the PESA CNIC- Santander Study published in the Journal of the American College of Cardiology (JACC)

The expression on lymphocytes of the molecule CD69 inversely predicts the development of subclinical (symptom-free) atherosclerosis independently of classical cardiovascular risk factors

The scientific event, which took place in Madrid, brought together more than 100 researchers from different fields of cardiovascular biology

The project is coordinated by Dr. José Antonio Enríquez and will receive funding worth $1350000 (€1^.100.062) over the next 3 years

The study is published in Science Translational Medicine and was conducted by researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC)

The OTRIs are intermediaries in the science-technology-enterprise system, and their mission is to boost relations among the agents of the system

The results of our research will allow an economic return of the investment in terms of reduction in the waiting lists, better use of the equipment or a decrease in the costs of hospitalization